Press Releases
Keyword Search
04.12.21
OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in COVID-19 Patients
03.25.21
OpGen Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
03.11.21
OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2020
03.08.21
OpGen Announces Publication of Final Study Results of Unyvero HPN Panel for Diagnosis of Bacterial Co-Infections in ICU Patients with COVID-19 Pneumonia
03.01.21
OpGen Wins Chinese NMPA Approval for the Curetis Unyvero System
02.16.21
OpGen Subsidiary Ares Genetics Announces Publication of Study Introducing Best Practice Techniques for AI-powered Prediction of Antibiotic Susceptibility Testing by Next-Generation Sequencing
02.09.21
OpGen, Inc. Announces $25 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules
01.13.21
OpGen Announces Preliminary Unaudited Revenue for Fiscal 2020 and Provides Business Update
01.05.21
OpGen Subsidiary Curetis and Annar Enter into Unyvero Distribution Partnership for Colombia
12.17.20
Results from 1,400 Patient Sample Multicenter Study Published: Unyvero LRT BAL Panel Provides Accurate Detection in Bronchoalveolar Lavage Fluid, Allowing Enhanced Diagnosis of Lower Respiratory Tract Infections